SGC Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Consolidated Revenue: $148 million, up 3% year-over-year.

Branded Products Revenue: $98 million, a 6% increase driven by higher volumes with existing customers.

Healthcare Apparel Revenue: $27 million, down 4% due to a noncash inventory write-down.

Contact Centers Revenue: $23 million, also down 4% but showing sequential improvement.

EBITDA: $7.7 million, a 27% increase from $6.1 million in Q2 2025.

Adjusted Diluted EPS: $0.21, significantly up from $0.10 in the prior year.

Gross Margin: 38%, down 40 basis points year-over-year; Branded Products gross margin improved to 36.5%.

SG&A as a Percent of Sales: 34.7%, improved by 160 basis points from the previous year.

Net Income: $1.2 million or $0.08 per diluted share; adjusted net income of $3.1 million after excluding a $2.6 million noncash impairment charge.

2Strategic Updates and Business Highlights

Branded Products: Strong growth attributed to existing customer volumes and improved gross margins. Continued investments in sales talent and technology are expected to drive long-term growth.

Healthcare Apparel: Facing challenges with a 4% revenue decline and margin pressure due to a strategic shift towards a focused product offering. New leadership is expected to implement changes for future growth.

Contact Centers: Sequential revenue improvement noted for the second consecutive quarter, driven by a larger pipeline of new business and improved efficiencies.

Cash Position: Ended Q2 with $23 million in cash; generated $18 million in operating cash flow in the first half of the year. Dividend payments totaled $2.2 million.

3Forward Guidance and Outlook

Full Year 2026 Guidance: Expected net sales of $572 million to $585 million and adjusted diluted EPS of $0.54 to $0.66, reflecting a back-half weighted growth strategy.

Healthcare Apparel: Anticipated continued margin pressure in the short term due to ongoing transitions.

Contact Centers: Expected to show sequential improvement in revenue and EBITDA margins in the second half of the year.

4Bad News, Challenges, or Points of Concern

Healthcare Apparel Segment: Experienced a revenue decline and margin pressure due to inventory write-downs and strategic shifts. Short-term challenges include potential ongoing margin pressure as new leadership implements changes.

Contact Centers: Revenue decline year-over-year, although sequential improvements are noted. Client attrition from 2025 remains a concern.

Market Conditions: General economic uncertainty impacting customer spending, particularly in the healthcare sector, where institutional customers are maintaining lean inventories.

5Notable Q&A Insights

Healthcare Apparel Changes: New leadership is focusing on product assortment and merchandising, which may lead to short-term margin pressures but is expected to improve in 2027.

Contact Centers Growth: Sequential improvement is anticipated to continue, driven by better customer conversion and internal efficiencies.

Branded Products Pipeline: Strong pipeline of opportunities with both existing and new customers, indicating potential for sustained growth despite slower decision-making processes.

M&A Activity: Potential for an acquisition in the Contact Centers business within the year, with a focus on enhancing service capabilities rather than pursuing typical promotional companies. Overall, SGC reported a solid quarter with notable growth in certain segments, while also facing challenges in others, particularly in Healthcare Apparel. The company remains optimistic about future growth driven by strategic investments and a strong customer pipeline.